NEW YORK – Roche Diagnostics announced today its Cobas Pro Integrated Solutions has received marketing clearance from the US Food and Drug Administration.
The Cobas Pro Integrated Solutions is Basel, Switzerland-based Roche's new generation of Serum Work Area lab solutions for both clinical chemistry and immunoassay platforms and are meant to help labs run tests faster on less equipment and automate manual tasks.
Intended for medium- to high- throughput labs, the solution allows for up to 2,200 tests per hour, with three modules working in parallel. It also takes 3 ¼ hours less time to operate compared to Roche's Cobas 6000, the company noted.
It also can run for 24 hours uninterrupted and has automated maintenance capabilities, along with 111 reagent positions and up to six months of reagent onboard stability.
The Cobas Pro Integrated Solutions was launched at the end of 2018 and is already cleared in countries that recognize the CE mark.